Organon & Co. (FRA:7XP)

Organon & Co. Statistics

Total Valuation

Organon & Co. has a market cap or net worth of EUR 1.70 billion. The enterprise value is 8.72 billion.

Market Cap	1.70B
Enterprise Value	8.72B

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	Nov 20, 2025

Share Statistics

Current Share Class	259.98M
Shares Outstanding	n/a
Shares Change (YoY)	+0.81%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	0.41%
Owned by Institutions (%)	78.04%
Float	258.67M

Valuation Ratios

The trailing PE ratio is 3.98 and the forward PE ratio is 2.02.

PE Ratio	3.98
Forward PE	2.02
PS Ratio	0.32
PB Ratio	2.20
P/TBV Ratio	n/a
P/FCF Ratio	2.57
P/OCF Ratio	2.10
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.78, with an EV/FCF ratio of 13.16.

EV / Earnings	20.41
EV / Sales	1.61
EV / EBITDA	5.78
EV / EBIT	7.52
EV / FCF	13.16

Financial Position

The company has a current ratio of 1.75, with a Debt / Equity ratio of 9.74.

Current Ratio	1.75
Quick Ratio	0.82
Debt / Equity	9.74
Debt / EBITDA	5.04
Debt / FCF	11.36
Interest Coverage	2.62

Financial Efficiency

Return on equity (ROE) is 71.62% and return on invested capital (ROIC) is 8.87%.

Return on Equity (ROE)	71.62%
Return on Assets (ROA)	6.40%
Return on Invested Capital (ROIC)	8.87%
Return on Capital Employed (ROCE)	12.39%
Revenue Per Employee	537,034
Profits Per Employee	42,700
Employee Count	10,000
Asset Turnover	0.48
Inventory Turnover	1.95

Taxes

In the past 12 months, Organon & Co. has paid 171.31 million in taxes.

Income Tax	171.31M
Effective Tax Rate	28.63%

Stock Price Statistics

The stock price has decreased by -56.04% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-56.04%
50-Day Moving Average	7.32
200-Day Moving Average	9.11
Relative Strength Index (RSI)	48.29
Average Volume (20 Days)	466

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.81

Income Statement

In the last 12 months, Organon & Co. had revenue of EUR 5.37 billion and earned 427.00 million in profits. Earnings per share was 1.63.

Revenue	5.37B
Gross Profit	2.99B
Operating Income	1.15B
Pretax Income	598.31M
Net Income	427.00M
EBITDA	1.44B
EBIT	1.15B
Earnings Per Share (EPS)	1.63

Balance Sheet

The company has 572.75 million in cash and 7.52 billion in debt, giving a net cash position of -6.95 billion.

Cash & Cash Equivalents	572.75M
Total Debt	7.52B
Net Cash	-6.95B
Net Cash Per Share	n/a
Equity (Book Value)	772.18M
Book Value Per Share	2.97
Working Capital	1.72B

Cash Flow

In the last 12 months, operating cash flow was 808.83 million and capital expenditures -146.60 million, giving a free cash flow of 662.24 million.

Operating Cash Flow	808.83M
Capital Expenditures	-146.60M
Free Cash Flow	662.24M
FCF Per Share	n/a

Margins

Gross margin is 55.67%, with operating and profit margins of 21.38% and 7.95%.

Gross Margin	55.67%
Operating Margin	21.38%
Pretax Margin	11.14%
Profit Margin	7.95%
EBITDA Margin	26.81%
EBIT Margin	21.38%
FCF Margin	12.33%

Dividends & Yields

This stock pays an annual dividend of 0.32, which amounts to a dividend yield of 4.84%.

Dividend Per Share	0.32
Dividend Yield	4.84%
Dividend Growth (YoY)	-69.11%
Years of Dividend Growth	n/a
Payout Ratio	31.54%
Buyback Yield	-0.81%
Shareholder Yield	4.03%
Earnings Yield	25.12%
FCF Yield	38.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Organon & Co. has an Altman Z-Score of 1.27 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.27
Piotroski F-Score	5